Skip to content
PreclinicalMitochondrialOralDailyNo human safety dataPartial data

SLU-PP-332

Pan-ERR (estrogen-related receptor) agonist that mimics exercise-induced metabolic adaptations in preclinical models.

◆ Editorial note

Small-molecule ERR agonist, not a peptide.

§ 01   Overview

Overview

Pan-ERR (estrogen-related receptor) agonist that mimics exercise-induced metabolic adaptations in preclinical models.

Only rodent data as of 2026. No human pharmacokinetic or safety data.

§ 02   Mechanism

Mechanism of action

SLU-PP-332 activates ERRα, β, and γ, which govern mitochondrial biogenesis and oxidative metabolism genes. In mice, it produces exercise-like improvements in endurance and body composition.

  • 01Exercise-mimetic effects in mice
  • 02Improved oxidative metabolism

§ 03   Dosing

Dosing protocol

Standard Protocol

Dose Range
Unknown; doses 1–400 mg anecdotally tried
Route
Oral
Frequency
Daily

§ 04   Evidence

Evidence & research

Preclinical

Only rodent data as of 2026. No human pharmacokinetic or safety data.

FDA Status

Not FDA-approved. Research chemical.

§ 06   News

In the news

2 articles from the last 12 months · updates hourly

§ 07   Sourcing

Sourcing & supply

Regulatory status

Research-only, no commercial channel

No commercial channel exists. Available only as a research reagent from RUO suppliers. Use in humans is not established.

No suppliers in our directory currently stock this compound. For investigational or research-only compounds, legitimate channels may not exist outside clinical trials.

Browse full supplier directory

§ 09   Safety

Safety & side effects

Side effects

  • 01Unknown

Contraindications

None specified.

§ 10   Questions

SLU-PP-332 FAQ

What is SLU-PP-332?
Pan-ERR (estrogen-related receptor) agonist that mimics exercise-induced metabolic adaptations in preclinical models. SLU-PP-332 activates ERRα, β, and γ, which govern mitochondrial biogenesis and oxidative metabolism genes. In mice, it produces exercise-like improvements in endurance and body composition.
What is SLU-PP-332 used for?
Reported uses include exercise-mimetic effects in mice and improved oxidative metabolism. Evidence strength is rated Preclinical — see the evidence section for detail.
How is SLU-PP-332 dosed?
Commonly referenced dosing is Unknown; doses 1–400 mg anecdotally tried, typically daily, administered Oral. This is educational reference only; consult a licensed clinician before use.
What are the side effects of SLU-PP-332?
Commonly reported side effects include unknown. This list is not exhaustive.
Is SLU-PP-332 legal?
No commercial channel exists. Available only as a research reagent from RUO suppliers. Use in humans is not established. FDA status: Not FDA-approved. Research chemical..

This site is for educational and research purposes only. It does not constitute medical advice. Always consult a qualified healthcare provider before using any peptide or supplement.